lavanducyanin: isolated from Steptomyces sp. CL190& from Streptomyces sp No.9659 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 129607 |
| MeSH ID | M0167962 |
| Synonym |
|---|
| ws 9659 a |
| 5-((2,4,4-trimethyl-1-cyclohexen-1-yl)methyl)-1(5h)-phenazinone |
| 1(5h)-phenazinone, 5-((2,4,4-trimethyl-1-cyclohexen-1-yl)methyl)- |
| lavanducyanin |
| yp 02978l-c |
| ws-9659a |
| ws 9659a |
| 5-[(2,4,4-trimethylcyclohexen-1-yl)methyl]phenazin-1-one |
| unii-lg9y6uj2un |
| lg9y6uj2un , |
| 122228-60-8 |
| DTXSID40153549 |
| AKOS040752449 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.82) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||